BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

NCT06741072 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

55

Enrollment

OTHER

Sponsor class

Stopped study drug issue

Conditions

Chronic Kidney Disease, Stage 4
Chronic Kidney Disease, Stage 5
EBV-Related Lymphoproliferative Disorder
EBV-Related Malignant Neoplasm
Post-Transplant Lymphoproliferative Disorder

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Dulbecco''s Phosphate-Buffered Saline
BIOLOGICAL: Peptide Vaccine
BIOLOGICAL: QS21

Sponsor

Ohio State University Comprehensive Cancer Center